Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective cohort study and analysis of transcriptomic predictors of response
Drennan P. et al, (2024), The Lancet Microbe
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
Taquet M. et al, (2024), The lancet. Psychiatry
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.
Elneima O. et al, (2024), ERJ open research, 10, 982 - 2023
Long COVID and cardiovascular disease: a prospective cohort study.
Lawson CA. et al, (2024), Open heart, 11
Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia
Liang Z. et al, (2024), Cell Reports, 43, 114152 - 114152
Transient synaptic CD61 pairing with CD103 increases the cytotoxicity of antigen-specific T cells.
(2024), Nature immunology, 25, 739 - 740
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity
Hamid MHBA. et al, (2024), Nature Immunology, 25, 834 - 846
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Liew F. et al, (2024), Nature Immunology, 25, 607 - 621
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Elneima O. et al, (2024), International Journal of Epidemiology, 53
Accelarated immune ageing is associated with COVID-19 disease severity.
Lord JM. et al, (2024), Immunity & ageing : I & A, 21
Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.
Guo L. et al, (2023), The Lancet. Microbe
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages.
Guo L. et al, (2023), Emerging microbes & infections, 12
Long COVID research: an update from the PHOSP-COVID Scientific Summit
Brightling CE. et al, (2023), The Lancet Respiratory Medicine, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
Raman B. et al, (2023), The Lancet Respiratory Medicine, 11, 1003 - 1019
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors.
Gu X. et al, (2023), EBioMedicine, 98
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Weeratunga P. et al, (2023), Nature communications, 14
SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses
Wellington D. et al, (2023), Heliyon, 9, e20076 - e20076
Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2
Antoun E. et al, (2023), Nature Immunology, 24, 1594 - 1596
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.
Chen Q. et al, (2023), Cellular & molecular immunology